摘要：AbstractThe use of mesenchymal stem cells (MSCs) for artificial bone graft production can meet the increasing demands of the tissue engineering market and provide off-the-shelf, safe and high quality material for grafting procedures. Herein, we present an integrated-modelling approach to describe the osteogenic differentiation of MSCs based on gene expression, cell cycle dynamics, and population balance equations.
